Selection, Characterization, Calibration, and Distribution of the U.S. Serology Standard for Anti-SARS-CoV-2 Antibody Detection.

Kemp, Troy J; Quesinberry, Jack T; Cherry, Jim; Lowy, Douglas R; Pinto, Ligia A

Kemp, Troy J; Quesinberry, Jack T; Cherry, Jim; Lowy, Douglas R; Pinto, Ligia A.

Afiliación

Kemp TJ; Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Researchgrid.418021.e, Frederick, Maryland, USA.
Quesinberry JT; Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Researchgrid.418021.e, Frederick, Maryland, USA.
Cherry J; Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
Lowy DR; Laboratory of Cellular Oncology, National Cancer Institutegrid.48336.3a, National Institutes of Health, Rockville, Maryland, USA.
Pinto LA; Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Researchgrid.418021.e, Frederick, Maryland, USA.

J Clin Microbiol ; 60(11): e0099522, 2022 11 16.

Article en En | MEDLINE | ID: mdl-36222529

Asunto(s)

COVID-19; SARS-CoV-2; Humanos; Estudios Seroepidemiológicos; Calibración; COVID-19/diagnóstico; Anticuerpos Antivirales; Inmunoglobulina M; Inmunoglobulina G; Glicoproteína de la Espiga del Coronavirus

Palabras clave

SARS-CoV-2; serology; standard

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Clin Microbiol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google